Evotec shares rise approximately 7% as 9-month preliminary results beat market expectations
EVO Evotec SE ADR
$1.35 -1.82%
View chart & analysis → - 1Evotec's 9-month group revenue is estimated at approximately 465 million euros.
- 2Evotec's 9-month adjusted group EBITDA is estimated at approximately minus 42.8 million euros.
- 3Evotec reaffirmed its 2026 annual guidance.
So what's the key point?
Evotec's 9-month revenue came in higher than experts expected. The company's stock rose about 7% as it reaffirmed its 2026 targets.
Source Investing.com · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.